{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T13:25:17Z","timestamp":1789997117435,"version":"4.0.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pancreatology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.pan.2018.07.003","type":"journal-article","created":{"date-parts":[[2018,7,7]],"date-time":"2018-07-07T15:42:22Z","timestamp":1530978142000},"page":"678-688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK\/AKT axis"],"prefix":"10.1016","volume":"18","author":[{"given":"Qing-Guo","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Ju","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pan.2018.07.003_bib1","doi-asserted-by":"crossref","first-page":"13343","DOI":"10.3748\/wjg.v20.i37.13343","article-title":"Gene therapy in pancreatic cancer","volume":"20","author":"Liu","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pan.2018.07.003_bib2","doi-asserted-by":"crossref","first-page":"7988","DOI":"10.3748\/wjg.v21.i26.7988","article-title":"Current status and progress of pancreatic cancer in China","volume":"21","author":"Lin","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pan.2018.07.003_bib3","doi-asserted-by":"crossref","first-page":"9694","DOI":"10.3748\/wjg.v22.i44.9694","article-title":"Epidemiology of pancreatic cancer","volume":"22","author":"Ilic","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pan.2018.07.003_bib4","first-page":"318","article-title":"Recent progress in pancreatic cancer","volume":"63","author":"Wolfgang","year":"2013","journal-title":"Ca - Cancer J Clin"},{"key":"10.1016\/j.pan.2018.07.003_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0140-6736(16)00141-0","article-title":"Pancreatic cancer","volume":"388","author":"Kamisawa","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.pan.2018.07.003_bib6","doi-asserted-by":"crossref","first-page":"11142","DOI":"10.3748\/wjg.v20.i32.11142","article-title":"Therapeutic options for the management of pancreatic cancer","volume":"20","author":"Rossi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pan.2018.07.003_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1097\/00006676-200010000-00004","article-title":"Expression of the multidrug-resistance 1 (MDR1) gene and prognosis in human pancreatic cancer","volume":"21","author":"Lu","year":"2000","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2018.07.003_bib8","doi-asserted-by":"crossref","first-page":"4455","DOI":"10.2147\/OTT.S130378","article-title":"miR-509-5p inhibits cellular proliferation and migration via targeting MDM2 in pancreatic cancer cells","volume":"10","author":"Li","year":"2017","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.pan.2018.07.003_bib9","doi-asserted-by":"crossref","first-page":"7091","DOI":"10.1158\/0008-5472.CAN-11-1367","article-title":"AGR2 is a novel surface antigen that promotes the dissemination of pancreatic cancer cells through regulation of cathepsins B and D","volume":"71","author":"Dumartin","year":"2011","journal-title":"Canc. Res"},{"key":"10.1016\/j.pan.2018.07.003_bib10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ydbio.2009.12.008","article-title":"Disruption of Paneth and goblet cell homeostasis and increased endoplasmic reticulum stress in Agr2-\/- mice","volume":"338","author":"Zhao","year":"2010","journal-title":"Dev Biol"},{"key":"10.1016\/j.pan.2018.07.003_bib11","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1038\/onc.2016.459","article-title":"ER stress protein AGR2 precedes and is involved in the regulation of pancreatic cancer initiation","volume":"36","author":"Dumartin","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.pan.2018.07.003_bib12","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s12032-015-0577-z","article-title":"Induction of anterior gradient 2 (AGR2) plays a key role in insulin-like growth factor-1 (IGF-1)-induced breast cancer cell proliferation and migration","volume":"32","author":"Li","year":"2015","journal-title":"Med Oncol"},{"key":"10.1016\/j.pan.2018.07.003_bib13","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/jpet.113.207563","article-title":"Silibinin induces cell death through reactive oxygen species-dependent downregulation of notch-1\/ERK\/Akt signaling in human breast cancer cells","volume":"349","author":"Kim","year":"2014","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.pan.2018.07.003_bib14","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00210-014-1071-4","article-title":"Lupeol inhibits proliferation and induces apoptosis of human pancreatic cancer PCNA-1 cells through AKT\/ERK pathways","volume":"388","author":"Liu","year":"2015","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1016\/j.pan.2018.07.003_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/MPA.0b013e3181bb2ab7","article-title":"Chemokine receptor CXCR4 enhances proliferation in pancreatic cancer cells through AKT and ERK dependent pathways","volume":"39","author":"Shen","year":"2010","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2018.07.003_bib16","first-page":"5830","article-title":"Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases","volume":"59","author":"Zhong","year":"1999","journal-title":"Canc. Res"},{"key":"10.1016\/j.pan.2018.07.003_bib17","first-page":"567","article-title":"Combined renal and vena caval trauma: a review of personal and recorded experience","volume":"133","author":"Peterson","year":"1985","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.pan.2018.07.003_bib18","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.jphotobiol.2016.05.027","article-title":"The role of photobiomodulation on gene expression of cell adhesion molecules in diabetic wounded fibroblasts in\u00a0vitro","volume":"161","author":"Ayuk","year":"2016","journal-title":"J\u00a0Photochem Photobiol, B"},{"key":"10.1016\/j.pan.2018.07.003_bib19","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.2147\/DDDT.S60328","article-title":"Pancreatic cancer: optimizing treatment options, new, and emerging targeted therapies","volume":"9","author":"Chiorean","year":"2015","journal-title":"Drug Des Dev Ther"},{"key":"10.1016\/j.pan.2018.07.003_bib20","first-page":"9354","article-title":"Pancreatic cancer: advances in treatment","volume":"20","author":"Mohammed","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pan.2018.07.003_bib21","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1158\/1078-0432.CCR-14-0289","article-title":"Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer","volume":"20","author":"Chan","year":"2014","journal-title":"Clin Canc Res"},{"key":"10.1016\/j.pan.2018.07.003_bib22","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11010-007-9562-y","article-title":"Physiological stress induces the metastasis marker AGR2 in breast cancer cells","volume":"306","author":"Zweitzig","year":"2007","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.pan.2018.07.003_bib23","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/pros.21273","article-title":"The anterior gradient 2 (AGR2) gene is overexpressed in prostate cancer and may be useful as a urine sediment marker for prostate cancer detection","volume":"71","author":"Bu","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.pan.2018.07.003_bib24","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1097\/MPA.0b013e3182a63bc3","article-title":"Anterior gradient 2 and mucin 4 expression mirrors tumor cell differentiation in pancreatic adenocarcinomas, but aberrant anterior gradient 2 expression predicts worse patient outcome in poorly differentiated tumors","volume":"43","author":"Brychtova","year":"2014","journal-title":"Pancreas"},{"key":"10.1016\/j.pan.2018.07.003_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1002\/ijc.23027","article-title":"ADH-1 suppresses N-cadherin-dependent pancreatic cancer progression","volume":"122","author":"Shintani","year":"2008","journal-title":"Int J Canc"},{"key":"10.1016\/j.pan.2018.07.003_bib26","first-page":"3265","article-title":"Silencing of X-linked inhibitor of apoptosis (XIAP) decreases gemcitabine resistance of pancreatic cancer cells","volume":"26","author":"Shrikhande","year":"2006","journal-title":"Anticancer Res"},{"key":"10.1016\/j.pan.2018.07.003_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1620\/tjem.234.83","article-title":"Expression of anterior gradient 2 is decreased with the progression of human biliary tract cancer","volume":"234","author":"Kim","year":"2014","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/j.pan.2018.07.003_bib28","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.1038\/onc.2010.228","article-title":"The pro-metastatic protein anterior gradient-2 predicts poor prognosis in tamoxifen-treated breast cancers","volume":"29","author":"Hrstka","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.pan.2018.07.003_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.canlet.2013.01.034","article-title":"Identification of an AKT-dependent signalling pathway that mediates tamoxifen-dependent induction of the pro-metastatic protein anterior gradient-2","volume":"333","author":"Hrstka","year":"2013","journal-title":"Canc Lett"},{"key":"10.1016\/j.pan.2018.07.003_bib30","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ccr.2010.05.023","article-title":"4E-BP1 is a key effector of the oncogenic activation of the AKT and ERK signaling pathways that integrates their function in tumors","volume":"18","author":"She","year":"2010","journal-title":"Canc Cell"},{"key":"10.1016\/j.pan.2018.07.003_bib31","doi-asserted-by":"crossref","first-page":"18301","DOI":"10.1074\/jbc.M110.215707","article-title":"The human adenocarcinoma-associated gene, AGR2, induces expression of amphiregulin through Hippo pathway co-activator YAP1 activation","volume":"286","author":"Dong","year":"2011","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pan.2018.07.003_bib32","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1093\/carcin\/bgs141","article-title":"Knockdown of AGR2 induces cellular senescence in prostate cancer cells","volume":"33","author":"Hu","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pan.2018.07.003_bib33","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.molonc.2014.03.005","article-title":"Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV-134","volume":"8","author":"Hashim","year":"2014","journal-title":"Mol Oncol"}],"container-title":["Pancreatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390318306288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1424390318306288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T16:06:24Z","timestamp":1761408384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1424390318306288"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S1424390318306288"],"URL":"https:\/\/doi.org\/10.1016\/j.pan.2018.07.003","relation":{},"ISSN":["1424-3903"],"issn-type":[{"value":"1424-3903","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knockdown of AGR2 induces cell apoptosis and reduces chemotherapy resistance of pancreatic cancer cells with the involvement of ERK\/AKT axis","name":"articletitle","label":"Article Title"},{"value":"Pancreatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pan.2018.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier B.V. on behalf of IAP and EPC.","name":"copyright","label":"Copyright"}]}}